查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392015

鼻减充血剂市场：按产品类型、按减充血剂类型、按作用机制、按应用、按配销通路、按地区

Decongestant Market, By Product Type, By Type of Decongestant (Oral Decongestants, Nasal Decongestants ), By Mode of Action, By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球鼻减充血剂市场规模预计将从 2023 年的 157.3 亿美元增至 2030 年的 246.7 亿美元，预测期内复合年增长率为 6.6%。

报告范围 报告详情
基准年 2022年 2023年市场规模 157.3亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.60% 2030年市场规模预测 246.7亿美元
图 1. 2023 年鼻减充血剂的全球市场占有率(%)，依地区划分
减充血剂市场-IMG1

鼻减充血剂是透过收缩鼻道血管来缓解鼻充血的药物。透过收缩鼻黏膜血管，鼻窦排放并减少肿胀。常见的鼻减充血剂包括伪麻黄碱和去氧肾上腺素。它们可以快速暂时缓解症状，用于治疗感冒、鼻窦、花粉症、过敏等。但不建议长期使用，因为药效过后鼻塞可能会復发。长期缓解包括生理食盐水鼻腔清洗、类固醇滴鼻剂和抗组织胺。过度使用或长期使用，尤其是鼻减充血喷雾剂，可能会导致反弹性充血，即停药后鼻道变得更加充盈。

市场动态：

全球鼻减充血剂市场正稳定成长，主要受到世界过敏盛行率上升的影响。主要的市场驱动因素包括由于环境条件变化和都市区空气污染导致季节性过敏性疾病迅速增加。此外，患者越来越意识到透过滴鼻剂和胶囊等便利的给药方式可以有效缓解鼻塞症状，这也推动了产品的采用。例如，大公司正在推出其产品的仿製药，以满足更广泛的患者群体。另一方面，成药处方鼻腔减充血药的可用性和可负担性正在增加市场收益。然而，关于定期使用超过 3 天的严格规定以及长期使用相关的副作用预计将阻碍市场成长。此外，到 2028 年之前，对皮质类固醇和免疫疗法等替代治疗方法的偏好也可能在一定程度上限制行业盈利。也就是说，旨在开发副作用较少的新配方的主要研发活动正在进行中，这可能会在预测期内为主要参与者提供有利的商机。

本研究的主要特点

  • 该报告对全球鼻充血减充血剂市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球鼻减充血剂市场的主要企业。
  • 该报告的见解将帮助行销人员和经营团队就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球鼻减充血剂市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 呼吸道疾病的传播
    • 鼻减充血剂副作用
    • 采用组合药物製剂
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 管道分析
  • 波特的分析
  • 併购场景

第四章全球鼻减充血剂市场－冠状冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球鼻减充血剂市场，依产品类型，2018-2030

  • 药片
  • 胶囊
  • 滴鼻剂
  • 其他的

第六章全球鼻减充血剂市场，按减充血剂类型，2018-2030

  • 口服减充血剂
  • 伪麻黄碱
  • 去氧肾上腺素
  • 其他的
  • 鼻减充血剂
  • 羟甲唑啉
  • 赛洛唑啉
  • 去氧肾上腺素
  • 萘甲唑啉
  • 其他的

第七章全球鼻减充血剂市场，依作用机制，2018-2030

  • α肾上腺素促效剂
  • 血管收缩剂
  • 其他的

第八章全球鼻减充血剂市场，依应用分类，2018-2030

  • 季节性过敏性鼻炎
  • 常年性过敏性鼻炎
  • 鼻窦
  • 鼻塞
  • 感冒或流感
  • 其他的

第 9 章全球鼻减充血剂市场，依配销通路，2018-2030 年

  • 医院药房
  • 零售药房
  • 线上药房
  • 大型超市/超市

第10章全球鼻减充血剂市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 雨美国
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第十一章竞争形势

  • Johnson & Johnson
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi SA
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Prestige Consumer Healthcare Inc.
  • Procter & Gamble Co.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd..
  • Perrigo Company plc
  • Church & Dwight Co., Inc.
  • Church & Dwight Co., Inc.
  • Mylan NV
  • Marinomed Biotech AG
  • Reddy's Laboratories Ltd

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5805

The global decongestant market size is expected to reach US$ 24.67 billion by 2030, from US$ 15.73 billion in 2023, at a CAGR of 6.6% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 15.73 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.60% 2030 Value Projection: US$ 24.67 Bn
Figure 1. Global Decongestant Market Share (%), By Region, 2023
Decongestant Market - IMG1

Decongestants are medications that help relieve nasal congestion by shrinking blood vessels in the nasal passages. They work by constricting the blood vessels in the nasal mucosa, which helps promote the drainage of sinus cavities and reduce swelling. Common decongestants include pseudoephedrine and phenylephrine. They provide rapid, temporary relief and are used to treat conditions like the common cold, sinusitis, hay fever, and allergies. However, prolonged use is not recommended, as rebound congestion may occur once the medication wears off. Alternative options for long-term relief include nasal saline rinses, steroid nasal sprays, and antihistamines. Overuse or prolonged use of nasal decongestant sprays, in particular, can lead to rebound congestion, where the nasal passages become more congested after the medication is discontinued.

Market Dynamics:

The global decongestant market is growing at a steady pace mainly influenced by rising prevalence of allergies worldwide. Some of the key market drivers include rapidly growing rate of seasonal allergy disorders fueled by changing environmental conditions and polluted urban atmospheres. Additionally, increasing patient awareness about effective symptomatic relief of nasal congestion through convenient delivery methods like nasal sprays and capsules is propelling the product adoption. For instance, major companies are launching generic copy products to cater wider patient segments. On the other hand, over-the-counter availability of several generic decongestants ensures easy accessibility and affordability augmenting market revenues. However, stringent regulations pertaining to regular consumption beyond 3 days along with adverse side effects associated with long term use are expected to hamper the market growth. Moreover, preference towards alternative treatment options like corticosteroids and immunotherapy may also limit the industry profitability to some extent through 2028. Nevertheless, ongoing R&D activities aimed at development of novel formulations with fewer side effects will likely create lucrative opportunities for key players over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global decongestant market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global decongestant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter & Gamble Co., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Church & Dwight Co., Inc., Mylan N.V. Marinomed Biotech AG, Dr. Reddy's Laboratories Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global decongestant market

Detailed Segmentation:

  • By Product Type:
    • Tablets
    • Capsules
    • Nasal Sprays
    • Others
  • By Type of Decongestant:
    • Oral Decongestants:
    • Pseudoephedrine
    • Phenylephrine
    • Others
    • Nasal Decongestants:
    • Oxymetazoline
    • Xylometazoline
    • Phenylephrine
    • Naphazoline
    • Others
  • By Mode of Action:
    • Alpha-Adrenergic Agonists
    • Vasoconstrictors
    • Others
  • By Application:
    • Seasonal Allergic Rhinitis
    • Perennial Allergic Rhinitis
    • Sinusitis
    • Nasal Congestion
    • Cold and Flu
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Hyper Market/Super Market
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi S.A.
    • Bayer AG
    • Reckitt Benckiser Group plc
    • Prestige Consumer Healthcare Inc.
    • Procter & Gamble Co.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Perrigo Company plc
    • Church & Dwight Co., Inc.
    • Mylan N.V.
    • Marinomed Biotech AG
    • Reddy's Laboratories Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Product Type
    • Market Snippet , By Type of Decongestant
    • Market Snippet , By Mode of Action
    • Market Snippet , By Application
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Prevalence of Respiratory Conditions
    • Side Effects of Decongestants
    • Adoption of combination drug formulations
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Decongestant Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Decongestant Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Decongestant Market, By Type of Decongestant, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral Decongestants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pseudoephedrine
  • Phenylephrine
  • Others
  • Nasal Decongestants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Oxymetazoline
  • Xylometazoline
  • Phenylephrine
  • Naphazoline
  • Others

7. Global Decongestant Market, By Mode of Action, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alpha-Adrenergic Agonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Vasoconstrictors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Decongestant Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Seasonal Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Perennial Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Sinusitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Nasal Congestion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cold and Flu
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Decongestant Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hyper Market/Super Market
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Global Decongestant Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Prestige Consumer Healthcare Inc.
  • Procter & Gamble Co.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd..
  • Perrigo Company plc
  • Church & Dwight Co., Inc.
  • Church & Dwight Co., Inc.
  • Mylan N.V.
  • Marinomed Biotech AG
  • Reddy's Laboratories Ltd
  • Analyst Views

12. Section

  • Research Methodology
  • About us